Skip to content

QuidelOrtho Corp (QDEL) stock: revenue, earnings & dividend

QuidelOrtho Corp (QDEL, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener QDEL · Nasdaq Pharma & Biotech US-CA

Key figures

Fiscal year
2025
Revenue
2.73 bn $
Revenue growth
-1.9 %
Revenue growth 5y (p.a.)
10.4 %
Net income
-1.13 bn $
Net margin
-41.5 %
Operating margin
-33.7 %
Earnings per share (diluted)
-16.69 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
5.77 bn $
Equity
1.92 bn $
Equity ratio
33.3 %
Return on equity
-58.9 %
Cash
170 m $
Operating cash flow
105 m $
Free cash flow
-83 m $
Shares outstanding
68,612,588

History

Revenue by fiscal year

2020 1.66 bn $
2021 1.7 bn $
2022 3.27 bn $
2023 3 bn $
2024 2.78 bn $
2025 2.73 bn $

Net income by fiscal year

2020 810 m $
2021 704 m $
2022 549 m $
2023 -10.1 m $
2024 -2.05 bn $
2025 -1.13 bn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.73 bn $-1.13 bn $-16.69 $–105 m $
20242.78 bn $-2.05 bn $-30.54 $–83 m $
20233 bn $-10.1 m $-0.15 $–280 m $
20223.27 bn $549 m $9.56 $–885 m $
20211.7 bn $704 m $16.43 $–806 m $
20201.66 bn $810 m $18.60 $–630 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)